Skip to main content
. Author manuscript; available in PMC: 2019 Feb 1.
Published in final edited form as: Int J Geriatr Psychiatry. 2017 Aug 6;33(2):e193–e198. doi: 10.1002/gps.4767

Table 1.

Baseline characteristics according to aspirin treatment.

Variable Aspirin (n=137) No aspirin (n=4003) P-valuea
Age (years) 65.3 (8.7) 61.3 (9.2) <0.0001
Females (%) 55.5 57.6 0.66
BMI (kg/m2) 29.1 (4.4) 28.4 (4.7) 0.14
White race (%) 78.1 81.9 0.26
PASE (points) 141.7 (69.9) 163.8 (82.1) 0.002
Smoking (previous/current) (%) 56.6 45.9 0.002
Degree (%) 31.6 32.2 0.93
Yearly income (<50,000 $) (%) 55.3 65.1 0.03

Charlson co-morbidity score 0.7 (1.1) 0.4 (0.8) <0.0001
Heart attack (%) 6.8 1.8 0.001
Heart failure (%) 6.7 1.7 <0.0001
Stroke (%) 8.2 2.4 0.001
Diabetes (%) 17.6 6.8 <0.0001
Use of NSAIDs (%) 19.7 23.9 0.31

CES-D (points) 4.6 (4.0) 4.8 (4.1) 0.65

Abbreviations: BMI Body Mass Index; PASE physical activity scale for the elderly; CES-D Center for Epidemiological Studies Depression.

Data are mean (SD) and percentage for continuous and categorical variables respectively.

a

P-values were calculated with Student’s t-tests and Chi-squared tests for continuous and categorical variables respectively.